Efficacy and safety of fluticasone propionate 250 μg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids
- 31 October 2002
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 89 (4) , 393-399
- https://doi.org/10.1016/s1081-1206(10)62041-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthmaAnnals of Allergy, Asthma & Immunology, 2001
- AsthmaNew England Journal of Medicine, 2001
- Efficacy and safety of dry powder fluticasone propionate in children with persistent asthmaAnnals of Allergy, Asthma & Immunology, 2000
- Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthmaJournal of Allergy and Clinical Immunology, 2000
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Comparative Efficacy and Safety of Twice Daily Fluticasone Propionate Powder Versus Placebo in the Treatment of Moderate AsthmaAnnals of Allergy, Asthma & Immunology, 1997
- Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging studyClinical Therapeutics, 1996
- A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of AsthmaJournal of Asthma, 1996
- Comparison of DiskusTMInhaler, a New Multidose Powder Inhaler, with DiskhalerTMInhaler for the Delivery of Salmeterol to Asthmatic PatientsJournal of Asthma, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994